Skip to content
Tempe Joint Field Guide
A local decision map for painful joints

Tempe Joint Field Guide

When is it time to have your joint checked?

Write down the time soreness begins and the task that brings it on. Mark down swelling, catching, buckling, or lost sleep. Include how long a flare lasts and what eases it. Those facts help the clinician use the visit well.

Why does the sore spot need a careful exam?

Soreness from a hip can reach the groin, thigh, or knee. A shoulder may hurt because of a tendon instead of the joint itself. Back or nerve trouble can also send soreness into an arm or leg. A procedure inside the joint can't help when the trouble begins elsewhere.

What home care is useful before the visit?

Keep using the joint within a comfortable range each day. Try shorter bouts of activity and rest before soreness climbs. Daily tasks may be easier with a brace or cane, while cold or warmth may settle a flare. Record what helps, since the clinician learns from what brings relief.

Which health facts can change the choice?

Bring a full list of medicines, including blood thinners and recent steroids. Tell the clinician about diabetes, recent illness, past reactions, and planned surgery. Keep taking each prescription until the person who ordered it tells you otherwise. General health advice can't guide that change safely.

Bring any brace, cane, or shoes that you use often. The clinician may watch how each one changes your movement. This can explain why some days feel easier.

When shouldn't you wait for a routine visit?

Seek prompt care when fever occurs as the joint grows hot and swollen. A fall, sudden loss of use, changed joint shape, or fast swelling also matters. The nerves serving your legs also help control your bladder and bowels. New leg weakness with bladder or bowel trouble can mean those nerves need urgent care. At QC Kinetix, regenerative treatments use blood drawn from you or marrow collected from bone; medical providers concentrate it and put it inside the aching joint.

Sources

  1. The HIT randomized trial (198 participants) found that adding a single ultrasound-guided triamcinolone-plus-lidocaine hip injection to best current treatment improved hip pain over six months (mean difference -1.43, 95% CI -2.15 to -0.72), but that the triamcinolone arm was NOT better than ultrasound-guided lidocaine alone; benefit was concentrated in patients with ultrasound-confirmed synovitis or effusion.

    Paskins Z, et al. — Clinical effectiveness of one ultrasound guided intra-articular corticosteroid and local anaesthetic injection in addition to advice and education for hip osteoarthritis (HIT trial): single blind, parallel group, three arm, randomised controlled trial.. BMJ, 2022. DOI: 10.1136/bmj-2021-068446.

  2. In a controlled cohort of 1,471 patients injected in the hip, 106 (7.2%) developed rapidly progressive idiopathic arthritis; compared with controls they were older, had narrower joint spaces and higher Croft scores before injection - so pre-injection joint severity, not the injectate or the anaesthetic, marked the at-risk group.

    Boutin RD, et al. — Rapidly progressive idiopathic arthritis of the hip: incidence and risk factors in a controlled cohort study of 1471 patients after intra-articular corticosteroid injection.. Skeletal Radiol, 2021. DOI: 10.1007/s00256-021-03815-7.

  3. A review of ten studies found single local corticosteroid injections caused a significant but TRANSIENT rise in blood glucose in patients with diabetes, with no adverse reactions or complications reported, and concluded such injections are most likely safe in people whose diabetes is well controlled.

    Waterbrook AL, et al. — Blood Glucose Levels After Local Musculoskeletal Steroid Injections in Patients With Diabetes Mellitus: A Clinical Review.. Sports Health, 2017. DOI: 10.1177/1941738117702585.

  4. A meta-analysis found ipsilateral intra-articular corticosteroid injection within 3 months BEFORE joint arthroplasty was associated with increased periprosthetic joint infection risk, and the authors recommend against performing arthroplasty on a joint injected within that window - while injections given at any time overall showed no such association.

    Lai Q, et al. — Prior Intra-articular Corticosteroid Injection Within 3 Months May Increase the Risk of Deep Infection in Subsequent Joint Arthroplasty: A Meta-analysis.. Clin Orthop Relat Res, 2022. DOI: 10.1097/CORR.0000000000002055.

  5. The 2019 ACR/Arthritis Foundation OA guideline makes a STRONG recommendation for intra-articular glucocorticoid injection in knee OA, alongside strong recommendations for exercise, weight loss, self-management, tai chi, cane use, bracing and NSAIDs; intra-articular steroid injection for HAND OA is only conditionally recommended.

    Kolasinski SL, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis Rheumatol, 2020. DOI: 10.1002/art.41142.

  6. The AAOS third-edition non-arthroplasty knee OA guideline (2022) issues 29 recommendations across non-pharmacologic and pharmacologic care, and its work group explicitly flagged the need for better research on intra-articular corticosteroid, hyaluronic acid and platelet-rich plasma.

    Brophy RH, et al. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. J Am Acad Orthop Surg, 2022. DOI: 10.5435/JAAOS-D-21-01233.

  7. A 2021 JAMA review of hip and knee osteoarthritis places intra-articular steroid injections as providing SHORT-TERM pain relief within a management model whose cornerstones are exercise, weight loss if appropriate and education, complemented by topical or oral NSAIDs, with joint replacement reserved for advanced symptoms and structural damage.

    Katz JN, et al. — Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.. JAMA, 2021. DOI: 10.1001/jama.2020.22171.

  8. A qualitative study interviewing 38 patients and 19 primary care clinicians found patients valued injections as an alternative to treatments they found undesirable, but reported wide variation in access, in onset and in how long the effect lasted; clinicians described an overarching theme of 'caution and competence', including uncertainty about the evidence and guidelines and the possibility of placebo.

    Moore AJ, et al. — Intra-articular corticosteroid injections for osteoarthritis: A qualitative study of patients' and clinicians' experiences.. PLoS One, 2024. DOI: 10.1371/journal.pone.0311668.

  9. A clinical review of peripheral joint injections frames them as a treatment for joint-mediated pain (arthritis, tendinopathy, bursitis) that has NOT responded to conservative management, and states plainly that these injections are typically not curative - their objective is to reduce pain enough to allow physical and pharmacologic rehabilitation to work.

    Marcolina A, et al. — Peripheral Joint Injections.. Phys Med Rehabil Clin N Am, 2022. DOI: 10.1016/j.pmr.2022.01.005.

  10. A 2024 AJR review of corticosteroid injection side effects lists local effects (post-injection flare, skin hypopigmentation and atrophy, infection, tendon rupture, accelerated osteoarthritis progression, osseous injury) and systemic effects (adrenal suppression, facial flushing, hypertension, hyperglycaemia, osteoporosis), and calls for targeted pre-injection counselling for specific populations.

    Kamel SI, et al. — Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications.. AJR Am J Roentgenol, 2024. DOI: 10.2214/AJR.23.30458.

  11. A meta-analysis of 10 RCTs of RECURRENT intra-articular corticosteroid injections (2-8 injections per patient) found they often gave inferior or non-superior relief compared with hyaluronic acid, PRP, saline or orgotein at 3 months and beyond, and no benefit over placebo in pain or function at 12-24 months.

    Donovan RL, et al. — Effects of recurrent intra-articular corticosteroid injections for osteoarthritis at 3 months and beyond: a systematic review and meta-analysis in comparison to other injectables.. Osteoarthritis Cartilage, 2022. DOI: 10.1016/j.joca.2022.07.011.

Would you like to talk with the clinic team?

Bring your medicine list, dates of past joint care, and notes about the soreness. Describe the daily task that soreness has made harder. Ask which care could follow when the first treatment doesn't help.

The nearest location for most Tempe neighborhoods is in Chandler at 1100 S. Dobson Rd., Suite 210. Call (602) 837-PAIN to discuss scheduling. The clinic can explain what happens during the visit.

Talk to the clinic team